Institute of Human Virology, University of Maryland School of Medicine, Baltimore 21201, USA.
Cytometry A. 2011 May;79(5):368-74. doi: 10.1002/cyto.a.21064. Epub 2011 Apr 14.
Improving access to CD4 testing in resource-limited settings can be achieved through both centralized and decentralized testing networks. Decentralized testing models are more suitable for countries where the HIV epidemic affects a large portion of rural populations. Timely access to accurate CD4 results is crucial at the primary level of the health system. For the past 7 years, the Institute of Human Virology of the University of Maryland School of Medicine has implemented a flexible and sustainable three-phase model: (1) site assessment and improvement, (2) appropriate technology selection with capacity building through practical training and laboratory mentoring, and (3) quality management system strengthening and monitoring, to support accessibility to reliable CD4 counting at the point of service. CD4 testing capacity was established in 122 of 229 (53%) laboratories supported in Nigeria, Uganda, Kenya, Zambia, Tanzania, and Rwanda. Among those in rural settings, 46% (69/151) had CD4 testing available at site level, with a functioning flow cytometer installed at 28% (8/29) and 50% (61/122) of level 1 and level 2 sites, respectively. To strengthen local capacity, a total of 1,152 laboratory technicians were trained through 188 training sessions provided both on-site and at central locations. The overall quality of CD4 total testing procedure was assessed at 76% (92/121) of the laboratories, with 25% (23/92), 34% (31/92), and 33% (30/92) of them reporting excellent, good, and satisfactory performance. Balancing country-specific factors with the location of the clinic, number of patients, and the expected workload, was crucial in adapting this flexible model for decentralizing CD4 testing. The close collaboration with local governments and private vendors was key to successfully expanding access to CD4 testing within the framework of HIV care and treatment programs and for the sustainability of medical laboratories in resource-limited settings.
在资源有限的环境下,可以通过集中式和分散式检测网络来改善 CD4 检测的可及性。分散式检测模型更适合于艾滋病疫情影响大部分农村人口的国家。在卫生系统的初级层面,及时获得准确的 CD4 结果至关重要。在过去的 7 年中,马里兰大学医学院人类病毒学研究所实施了一种灵活和可持续的三阶段模式:(1)现场评估和改进,(2)通过实际培训和实验室指导选择适当的技术并进行能力建设,以及(3)加强质量管理体系并进行监测,以支持在服务点获得可靠的 CD4 计数。在尼日利亚、乌干达、肯尼亚、赞比亚、坦桑尼亚和卢旺达的 229 个实验室中,有 122 个(53%)建立了 CD4 检测能力。在农村地区,46%(69/151)的实验室可以进行 CD4 检测,其中 28%(8/29)和 50%(61/122)的一级和二级实验室分别配备了功能齐全的流式细胞仪。为了加强当地能力,通过现场和中央地点提供的 188 次培训课程,共培训了 1152 名实验室技术人员。对 76%(92/121)的实验室进行了 CD4 总检测程序的整体质量评估,其中 25%(23/92)、34%(31/92)和 33%(30/92)的实验室报告了优秀、良好和满意的性能。在适应分散式 CD4 检测的过程中,平衡国家具体因素、诊所位置、患者数量和预期工作量至关重要。与当地政府和私营供应商密切合作是在艾滋病毒护理和治疗方案框架内成功扩大 CD4 检测范围并维持资源有限环境下医疗实验室可持续性的关键。